Apart from some redness, bruising, and swelling, there are a few side effects associated with this procedure
The bottom line No arrows from existing clinical evidence point to starting a GLP-1 drug with the intention of microdosing it
adults who are overweight and have a weight-related medical problem (e.g., blood pressure, type 2 diabetes, or high cholesterol) To reduce the risk of major adverse CV events in: adults with established cardiovascular disease who have obesity or are overweight
[9] Stool softeners such as docusate sodium (Colace) have limited evidence for effectiveness
Our clinic knows each persons weight loss trip is different
Research suggests that after stopping GLP-1 medications, A1C, fasting blood glucose, body weight, waist circumference and systolic blood pressure can increase, so your provider may want to repeat labs, adjust other medications or monitor your blood sugar more closely